Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and RamSoft®, a global leader in ...

Researchers examined screening rates for three kinds of cancer before, during, and after the COVID-19 pandemic.

The use of artificial intelligence in the healthcare industry continues to grow. University Hospitals has acquired new ...

The AI model processes pre-contrast and a single post-contrast T1 image, identifying suspicious regions and assigning a ...

Megan Shellhorn, local mom, breast cancer survivor founds Pink Lights the Way to help patients find support DOGE ...

Researchers at the Icahn School of Medicine at Mount Sinai (NY, USA) have developed a computational model that can predict ...

As part of the Summer Research Symposium, a panel of School of Medicine faculty members select outstanding posters for ...

CEO transition Teri Thomas, who has led Volpara since 2022, played a key role in the company's transformation, strengthening its AI platform and overseeing its 2024 acquisition by Lunit. Under her ...